Skip to content

Early detection of basal cell carcinoma in a dermatologic risk population using line-field confocal optical coherence tomography (LC-OCT) addressing the extent of skin aging

Early detection of basal cell carcinoma in a dermatologic risk population using line-field confocal optical coherence tomography (LC-OCT) addressing the extent of skin aging

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00036702
Enrollment
150
Registered
2025-06-04
Start date
2025-04-23
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Basalcellcarcinom of the facial skin

Interventions

Group 1: In patients with an increased risk of developing basal cell carcinoma (see inclusion criteria), an examination of the entire facial skin with line-field confocal optical coherence tomography

Sponsors

Uniklinikum Erlangen, Hautklinik
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Written informed consent to the study - Presence of at least two of the following risk factors for basal cell carcinoma: -- Age = 65 years -- Skin type I or II according to Fitzpatrick scale -- Diagnosis of basal cell carcinoma in the past -- Chronic exposure to sunlight --- of at least 20 years in the context of professional activity or --- of at least 30 years in the context of leisure activities -- Diagnosis of a genetic syndrome with an increased risk of developing basal cell carcinoma (Gorlin-Goltz syndrome, Bazex-Dupré-Christol syndrome, Rombo syndrome) -- Condition after radiotherapy in the head/neck area

Exclusion criteria

Exclusion criteria: - Insufficient cognitive capacity to consent to the study - Presence of a skin disease in the examination area which significantly restricts the examination conditions (e.g. but not limited to extensive nevus flammeus, acne conglobata) in the opinion of the investigator - Disease or condition that makes examination with LC-OCT impossible - Previous participation in the study

Design outcomes

Primary

MeasureTime frame
Relative number of subclinical basal cell carcinomas (number of subclinical basal cell carcinomas per patient examined) diagnosed and histologically verified by LC-OCT examination

Secondary

MeasureTime frame
Relative number of false positive findings (number of sample biopsies that are performed on the basis of a diagnosis of basal cell carcinoma using LC-OCT and cannot be confirmed histologically)

Countries

Germany

Contacts

Public ContactCarola Berking

Uniklinikum Erlangen, Hautklinik

carola.berking@uk-erlangen.de+4991318533851

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026